|
1
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rasheed ZA, Yang J, Wang Q, Kowalski J,
Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, et
al: Prognostic significance of tumorigenic cells with mesenchymal
features in pancreatic adenocarcinoma. J Natl Cancer Inst.
102:340–351. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dangi-Garimella S, Krantz SB, Shields MA,
Grippo PJ and Munshi HG: Epithelial-mesenchymal transition and
pancreatic cancer progression. Pancreatic Cancer and Tumor
Microenvironment. Grippo PJ and Munshi HG: Trivandrum (India):
Transworld Research Network; 2012, Chapter 5 Available from:
https://www.ncbi.nlm.nih.gov/books/NBK98932/.
|
|
6
|
Zhang H, von Gise A, Liu Q, Hu T, Tian X,
He L, Pu W, Huang X, He L, Cai CL, et al: Yap1 is required for
endothelial to mesenchymal transition of the atrioventricular
cushion. J Biol Chem. 289:18681–18692. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Molloy SS, Bresnahan PA, Leppla SH,
Klimpel KR and Thomas G: Human furin is a calcium-dependent serine
endopro-tease that recognizes the sequence Arg-X-X-Arg and
efficiently cleaves anthrax toxin protective antigen. J Biol Chem.
267:16396–16402. 1992.PubMed/NCBI
|
|
8
|
Walker JA, Molloy SS, Thomas G, Sakaguchi
T, Yoshida T, Chambers TM and Kawaoka Y: Sequence specificity of
furin, a proprotein-processing endoprotease, for the hemagglutinin
of a virulent avian influenza virus. J Virol. 68:1213–1218.
1994.PubMed/NCBI
|
|
9
|
Seidah NG, Mayer G, Zaid A, Rousselet E,
Nassoury N, Poirier S, Essalmani R and Prat A: The activation and
physiological functions of the proprotein convertases. Int J
Biochem Cell Biol. 40:1111–1125. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Artenstein AW and Opal SM: Proprotein
convertases in health and disease. N Engl J Med. 365:2507–2518.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
López de Cicco R, Bassi DE, Zucker S,
Seidah NG and Klein-Szanto AJ: Human carcinoma cell growth and
invasiveness is impaired by the propeptide of the ubiquitous
proprotein convertase furin. Cancer Res. 65:4162–4171. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scamuffa N, Sfaxi F, Ma J, Lalou C, Seidah
N, Calvo F and Khatib AM: Prodomain of the proprotein convertase
subtilisin/kexin Furin (ppFurin) protects from tumor progression
and metastasis. Carcinogenesis. 35:528–536. 2014. View Article : Google Scholar
|
|
13
|
Fu J, Bassi DE, Zhang J, Li T, Nicolas E
and Klein-Szanto AJ: Transgenic overexpression of the proprotein
convertase furin enhances skin tumor growth. Neoplasia. 14:271–282.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scamuffa N, Siegfried G, Bontemps Y, Ma L,
Basak A, Cherel G, Calvo F, Seidah NG and Khatib AM: Selective
inhibition of proprotein convertases represses the metastatic
potential of human colorectal tumor cells. J Clin Invest.
118:352–363. 2008. View
Article : Google Scholar
|
|
15
|
Bassi DE, Mahloogi H, Lopez De Cicco R and
Klein-Szanto A: Increased furin activity enhances the malignant
phenotype of human head and neck cancer cells. Am J Pathol.
162:439–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng M, Watson PH, Paterson JA, Seidah N,
Chrétien M and Shiu RP: Pro-protein convertase gene expression in
human breast cancer. Int J Cancer. 71:966–971. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Page RE, Klein-Szanto AJ, Litwin S,
Nicolas E, Al-Jumaily R, Alexander P, Godwin AK, Ross EA, Schilder
RJ and Bassi DE: Increased expression of the pro-protein convertase
furin predicts decreased survival in ovarian cancer. Cell Oncol.
29:289–299. 2007.PubMed/NCBI
|
|
18
|
Bax NA, van Oorschot AA, Maas S, Braun J,
van Tuyn J, de Vries AA, Groot AC and Goumans MJ: In vitro
epithelial-to-mesenchymal transformation in human adult epicardial
cells is regulated by TGFβ-signaling and WT1. Basic Res Cardiol.
106:829–847. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Overholtzer M, Zhang J, Smolen GA, Muir B,
Li W, Sgroi DC, Deng CX, Brugge JS and Haber DA: Transforming
properties of YAP, a candidate oncogene on the chromosome 11q22
amplicon. Proc Natl Acad Sci USA. 103:12405–12410. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shao DD, Xue W, Krall EB, Bhutkar A,
Piccioni F, Wang X, Schinzel AC, Sood S, Rosenbluh J, Kim JW, et
al: KRAS and YAP1 converge to regulate EMT and tumor survival.
Cell. 158:171–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Diepenbruck M, Waldmeier L, Ivanek R,
Berninger P, Arnold P, van Nimwegen E and Christofori G: Tead2
expression levels control the subcellular distribution of Yap and
Taz, zyxin expression and epithelial-mesenchymal transition. J Cell
Sci. 127:1523–1536. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pei D and Weiss SJ: Furin-dependent
intracellular activation of the human stromelysin-3 zymogen.
Nature. 375:244–247. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yana I and Weiss SJ: Regulation of
membrane type-1 matrix metalloproteinase activation by proprotein
convertases. Mol Biol Cell. 11:2387–2401. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dubois CM, Blanchette F, Laprise MH, Leduc
R, Grondin F and Seidah NG: Evidence that furin is an authentic
transforming growth factor-beta1-converting enzyme. Am J Pathol.
158:305–316. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Duguay SJ, Jin Y, Stein J, Duguay AN,
Gardner P and Steiner DF: Post-translational processing of the
insulin-like growth factor-2 precursor. Analysis of O-glycosylation
and endoproteolysis. J Biol Chem. 273:18443–18451. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lopez de Cicco R, Watson JC, Bassi DE,
Litwin S and Klein-Szanto AJ: Simultaneous expression of furin and
vascular endothelial growth factor in human oral tongue squamous
cell carcinoma progression. Clin Cancer Res. 10:4480–4488. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maret D, Gruzglin E, Sadr MS, Siu V, Shan
W, Koch AW, Seidah NG, Del Maestro RF and Colman DR: Surface
expression of precursor N-cadherin promotes tumor cell invasion.
Neoplasia. 12:1066–1080. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun X, Essalmani R, Seidah NG and Prat A:
The proprotein convertase PC5/6 is protective against intestinal
tumorigenesis: In vivo mouse model. Mol Cancer. 8:732009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maret D, Sadr MS, Sadr ES, Colman DR, Del
Maestro RF and Seidah NG: Opposite roles of furin and PC5A in
N-cadherin processing. Neoplasia. 14:880–892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen X, Halberg RB, Burch RP and Dove WF:
Intestinal adenomagenesis involves core molecular signatures of the
epithelial-mesenchymal transition. J Mol Histol. 39:283–294. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bassi DE, Mahloogi H and Klein-Szanto AJ:
The proprotein convertases furin and PACE4 play a significant role
in tumor progression. Mol Carcinog. 28:63–69. 2000. View Article : Google Scholar : PubMed/NCBI
|
